One glance at the Conway Projects Database shows this progress. From Microsoft’s $3.3 AI data center development in Mount Pleasant to Eli Lilly’s $3.5 billion expansion of its pharmaceutical manufacturing campus in Kenosha County, Wisconsin is experiencing a technology and manufacturing boom.
On December 16, 2024, the Village of Pleasant Prairie Plan Commission approved the Preliminary Site and Operational Plans for the proposed expansion of the Eli Lilly and Company facility located at 10300 128th Avenue in the Prairie Highlands Corporate Park.
_med.jpg)
INDIANAPOLIS, Dec. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a $3 billion expansion of the Kenosha County, Wisconsin, manufacturing facility that the company acquired earlier this year.
On an investment spree with billions of dollars worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company chose Kenosha County for its latest — and one of its largest — investments.
The pharmaceutical giant announced Thursday that it was planning a $3 billion expansion in Pleasant Prairie at a site formerly home to Nexus Pharmaceuticals. The company expects to create 750 new jobs there as part of the expansion. Approximately 100 employees already work at the roughly 100,000-square-foot facility at 10300 128th Ave. in the Prairie Highlands Corporate Park.
INDIANAPOLIS and LINCOLNSHIRE, Ill., April 22, 2024 – Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC today announced a definitive agreement for Lilly to acquire a manufacturing facility from Nexus, a leading sterile manufacturer in the pharmaceutical industry.